This was an “open-label” study. This means the participants, researchers, study
doctors, and other study staff knew what each participant was taking.
The chart below shows the treatments the researchers planned to study.
Treatment 1 Treatment 2 Treatment 3
14 participants
• Verinurad as a • Verinurad as a • Verinurad as a
capsule by mouth capsule by mouth capsule by mouth
• Allopurinol as a • Allopurinol as a • Allopurinol as a
tablet by mouth tablet by mouth tablet by mouth
• Cyclosporine as a • Rifampicin as a
capsule by mouth tablet by mouth
• Once • Once, 5 days after • Once, at least
Treatment 1 2 weeks after
Treatment 2
4 | Clinical Study Results